Institution
Department of Biotechnology
Government•New Delhi, India•
About: Department of Biotechnology is a government organization based out in New Delhi, India. It is known for research contribution in the topics: Population & Silver nanoparticle. The organization has 4800 authors who have published 5033 publications receiving 82022 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Histological study of ovary sections revealed abnormalities in follicular epithelial cells due to AZA treatment, which indicates that AZA significantly inhibits the activity of AChE only at the high dose.
145 citations
••
TL;DR: The prepared composite has great potential for recovering phosphorus from wastewater, and the phosphate sorbed composite can be employed as a promising phosphorus slow-releasing fertilizer for improving plant growth.
145 citations
••
TL;DR: In this article, the feasibility of biochar amended with lime to reduce the loss of ammonia, greenhouse gas (GHG) emissions and the bio-availability of heavy metals (HMs) during composting of dewatered fresh sewage sludge (DFSS) and to improve the end product quality was evaluated.
145 citations
••
TL;DR: In this paper, the authors highlighted the extensive use of the face mask and how it affects human health and the marine ecosystem and highlighted the evolutionary importance, taxonomy, genomic structure, transmission to humans, prevention, and treatment.
145 citations
••
TL;DR: Biofilm-associated Candida show uniform resistance to a wide spectrum of antifungal drugs and a combination of different resistance mechanisms is responsible for drug resistance in clinical isolates of Candida species.
Abstract: Pathogenic yeasts from the genus Candida can cause serious infection in humans particularly, in immunocompromised patients and are now recognized as major agents of hospital acquired (nosocomial) infections. In the recent years, there has been a marked increase in the incidence of treatment failures in candidiasis patients receiving long-term antifungal therapy, which has posed a serious problem in its successful use in chemotherapy. Candida cells acquire drug resistance (MDR) during the course of the treatment. The mechanisms of resistance to azole antifungal agents have been elucidated in Candida species and can be mainly categorized as (i) changes in the cell wall or plasma membrane, which lead to impaired drug (azole) uptake; (ii) alterations in the affinity of the drug target Erg11p (lanosterol 14alpha-demethylase) especially to azoles or in the cellular content of Erg11p due to target site mutation or overexpression of the ERG11 gene; and (iii) the efflux of drugs mediated by membrane transport proteins belonging to the ATP-binding cassette (ABC) transporters, namely CDR1 and CDR2 or to the major facilitator superfamily (MFS) transporter, CaMDR1. Many such manifestations are associated with the formation of Candida biofilms including those occurring on devices like indwelling intravascular catheters. Biofilm-associated Candida show uniform resistance to a wide spectrum of antifungal drugs. A combination of different resistance mechanisms is responsible for drug resistance in clinical isolates of Candida species.
145 citations
Authors
Showing all 4812 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ashok Pandey | 96 | 796 | 43038 |
Klaus Becker | 79 | 320 | 27494 |
Bansi D. Malhotra | 75 | 375 | 19419 |
Ashwani Kumar | 66 | 703 | 18099 |
Sanjay K. Banerjee | 62 | 798 | 30044 |
M. Michael Gromiha | 56 | 352 | 10617 |
Swaran J.S. Flora | 55 | 267 | 11434 |
Mallappa Kumara Swamy | 54 | 864 | 14508 |
Pulok K. Mukherjee | 54 | 296 | 10873 |
Mukesh Doble | 51 | 364 | 9826 |
Jaya Narayan Sahu | 49 | 157 | 9569 |
Pradeep Das | 49 | 426 | 10118 |
Jon R. Lorsch | 48 | 117 | 7661 |
Rakesh Tuli | 47 | 165 | 7497 |
Amit K. Goyal | 47 | 157 | 5749 |